TABLE II.
Bone | Marrow | Fibrous tissue | |
---|---|---|---|
Ongrowth | |||
P-Ti | 3 (0–3) | 33 (21–50) | 56 (45–76) |
P-HA | 51 (20–62)a | 33 (10–35) | 15 (2–71) |
E-HA | 18 (5–25)a | 54 (32–68)b | 21 (17–64)a |
E-HA-collagen | 21 (13–27)a | 53 (36–69)b | 21 (1–55) |
0–500 µm | |||
P-Ti | 11 (10–16) | 71 (52–77) | 13 (12–17) |
P-HA | 18 (11–27) | 65 (61–69) | 9 (1–27) |
E-HA | 24 (11–28)a | 67 (51–75) | 11 (4–16) |
E-HA-collagen | 19 (14–32) | 67 (58–79) | 4 (1–12)a |
500–1000 µm | |||
P-Ti | 11 (6–18) | 80 (72–88) | 0.1 (0–0.7) |
P-HA | 13 (10–29) | 81 (69–85) | 0 (0–0.2) |
E-HA | 19 (14–22)a | 75 (72–83) | 0 (0–0.5) |
E-HA-collagen | 19 (14–27) | 76 (62–79) | 0.3 (0–2) |
Density (percentage) of bone, marrow-like and fibrous tissue at the implant surface, concentric zone 0–500 µm and 500–1000 µm.
Median, interquartile ranges. n = 7.
P-Ti, plasma spray titanium alloy; P-HA, plasma spray hydroxyapatite coating; E-HA, electrochemical-assisted hydroxyapatite coating; E-HA-Col, electrochemical-assisted hydroxyapatite mineralised collagen coating.
p < 0.05 compared with titanium.
p < 0.05 compared with HA plasma.